[20 years of perinatal epidemiology. The clinician's viewpoint]

E Papiernik1

  • 1Hôpital Cochin, Service de Gynécologie-Obstétrique I, Paris.

Revue D'Epidemiologie Et De Sante Publique
|November 1, 1996
PubMed

Insights

France

Area of Science:

  • Public Health
  • Maternal and Child Health
  • Healthcare Policy

Context:

  • The evolution of French perinatal health policies from 1971 to the present.
  • Shift from national initiatives to departmental responsibility and back to a collective approach.
  • Impact of cost-effectiveness analysis and national surveys on policy development.

Purpose:

  • To describe the historical development and policy shifts in French perinatal care.
  • To evaluate the effectiveness of national actions in reducing perinatal mortality and morbidity.
  • To highlight the changing perceptions of maternal mortality risk and the approach to safe birth.

Summary:

  • The first period (1971-1981) focused on reducing perinatal mortality through national policies informed by cost-effectiveness analysis, leading to decreased prematurity and mortality rates.
  • The second period saw a decentralization of perinatal health actions, with varied departmental initiatives.
  • The third period (post-1994) re-emphasized a collective approach to safe birth, informed by a renewed focus on maternal mortality risk.

Impact:

  • Successful reduction in prematurity and perinatal mortality during the initial national plan.
  • Demonstrated the importance of national strategies and subsequent departmental actions in improving perinatal outcomes.
  • Established a precedent for evidence-based policy-making in maternal and child health.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...